FOXP1 and cancer: We further show that skeletal-muscle FoxP1 is a key mediator of these disruptions in response to cancer, which may be mediated, at least in part, through direct binding and dysregulation of core clock genes, clock-controlled genes, and genes involved in muscle catabolism.